RBP3 and macular telangiectasia type 2: Anti-IRBP autoantibodies have been found in patients with uveitis, RP, Coats disease, AMD and Macular Telangiectasia Type 2 (MacTel) (Solomon et al., 1999; Morohoshi et al., 2012; Kyger et al., 2013; Zhu et al., 2013; Gibbs et al., 2017).